The Community Guide

- gsearch

Search Results

Narrow Results:

2018 1
2016 1
2015 2

Gabon 1
Kenya 1

Journal Article 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy

CITE Title : Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy Personal Author(s) : Haaland, Richard E.;Otieno, Kephas;Martin, Amy;Katana, Abraham;Dinh, Chuong;Slutsker, Laurence;Menendez, Clara;Gonzalez, Raquel;Williamson, John;Heneine, Walid;Desai, Meghna; Published Date : Oct 17 2018 Source : AIDS Res Hum Retroviruses. 2018; 34(11):912-915. URL : https://stacks.cdc.gov/view/cdc/60780 Haaland, Richard E. et al. (2018). Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy. 34(11). Haaland, Richard E. et al. "Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy" 34, no. 11 (2018) Haaland, Richard E. et al. "Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy" vol. 34, no. 11, 2018 Export RIS Citation Information.

:

Haaland, Richard E. ;

Otieno, Kephas

Oct 17 2018 | AIDS Res Hum Retroviruses. 2018; 34(11):912-915.

:

Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an un...
Loa loa Infection in Pregnant Women, Gabon

CITE Title : Loa loa Infection in Pregnant Women, Gabon Personal Author(s) : Mombo-Ngoma, Ghyslain;Mackanga, Jean Rodolphe;Basra, Arti;Capan, Meskure;Manego, Rella Zoleko;Adegnika, Ayôla Akim;Lötsch, Felix;Yazdanbakhsh, Maria;González, Raquel;Menendez, Clara;Mabika, Barthelemy;Matsiegui, Pierre Blaise;Kremsner, Peter G.;Ramharter, Michael; Published Date : May 2015 Source : Emerg Infect Dis. 21(5):899-901. URL : https://stacks.cdc.gov/view/cdc/30896 Mombo-Ngoma, Ghyslain et al. (2015). Loa loa Infection in Pregnant Women, Gabon. 21(5). Mombo-Ngoma, Ghyslain et al. "Loa loa Infection in Pregnant Women, Gabon" 21, no. 5 (2015) Mombo-Ngoma, Ghyslain et al. "Loa loa Infection in Pregnant Women, Gabon" vol. 21, no. 5, 2015 Export RIS Citation Information.

:

Mombo-Ngoma, Ghyslain ;

Mackanga, Jean Rodolphe

May 2015 | Emerg Infect Dis. 21(5):899-901.

No Description
Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya

CITE Title : Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya Personal Author(s) : Green, Michael;Otieno, Kephas;Katana, Abraham;Slutsker, Laurence;Kariuki, Simon;Ouma, Peter;González, Raquel;Menendez, Clara;ter Kuile, Feiko;Desai, Meghna; Published Date : Jan 05 2016 Source : Malar J. 15. URL : https://stacks.cdc.gov/view/cdc/37732 Green, Michael et al. (2016). Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya. 15 Green, Michael et al. "Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya" 15 (2016) Green, Michael et al. "Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya" vol. 15, 2016 Export RIS Citation Information.

:

Green, Michael ;

Otieno, Kephas

Jan 05 2016 | Malar J. 15.

:

BackgroundIntermittent preventive treatment in pregnancy with sulfadoxine/pyrimethamine is contra-indicated in HIV-positive pregnant women receiving s...
Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique

CITE Title : Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique Personal Author(s) : Tinto, Halidou;Sevene, Esperança;Dellicour, Stephanie;Calip, Gregory S.;d’Alessandro, Umberto;Macete, Eusébio;Nakanabo-Diallo, Seydou;Kazienga, Adama;Valea, Innocent;Sorgho, Hermann;Valá, Anifa;Augusto, Orvalho;Ruperez, Maria;Menendez, Clara;Ouma, Peter;Desai, Meghna;Ter Kuile, Feiko;Stergachis, Andy; Published Date : Dec 04 2015 Source : Reprod Health. 12. URL : https://stacks.cdc.gov/view/cdc/36626 Tinto, Halidou et al. (2015). Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. 12 Tinto, Halidou et al. "Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique" 12 (2015) Tinto, Halidou et al. "Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique" vol. 12, 2015 Export RIS Citation Information.

:

Tinto, Halidou ;

Sevene, Esperança

Dec 04 2015 | Reprod Health. 12.

:

BackgroundA major unresolved safety concern for malaria case management is the use of artemisinin combination therapies (ACTs) in the first trimester ...